Andreas Pahl
Chief Executive Officer at HEIDELBERG PHARMA AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Georg F. Baur | M | 74 | 24 years | |
| Christof Hettich | M | 64 | 14 years | |
| Sylvia Wimmer | F | - | 25 years | |
| Friedrich von Bohlen und Halbach | M | 60 | 19 years | |
| Birgit Kudlek | M | 57 | 12 years | |
| Mathias Hothum | M | 58 | 9 years | |
| Walter Miller | M | - | 1 years | |
| Dong Zhou Liu | M | - | 2 years | |
| Jörg Kemkowski | M | - | 1 years | |
| András Strassz | M | - | 3 years | |
| George Badescu | M | - | 3 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan Schmidt-Brand | M | - |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The private company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | 20 years |
| Peter Llewellyn-Davies | M | 66 | 6 years | |
| Olaf G. Wilhelm | M | - | 17 years | |
| Charlotte Lohmann | F | 54 | 11 years | |
| Andreas Krebs | M | 66 | 6 years | |
| Thomas Borcholte | M | - | 6 years | |
| Paul Bevan | M | - | 13 years | |
| Mathias Locher | M | - | 2 years | |
| Xu Min Zhao | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andreas Pahl
- Personal Network
